113 related articles for article (PubMed ID: 12386807)
1. Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum.
Weiss WA; Israel M; Cobbs C; Holland E; James CD; Louis DN; Marks C; McClatchey AI; Roberts T; Van Dyke T; Wetmore C; Chiu IM; Giovannini M; Guha A; Higgins RJ; Marino S; Radovanovic I; Reilly K; Aldape K
Oncogene; 2002 Oct; 21(49):7453-63. PubMed ID: 12386807
[TBL] [Abstract][Full Text] [Related]
2. Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models.
Rice JM
Toxicol Appl Pharmacol; 2004 Sep; 199(2):175-91. PubMed ID: 15313589
[TBL] [Abstract][Full Text] [Related]
3. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
Hruban RH; Adsay NV; Albores-Saavedra J; Anver MR; Biankin AV; Boivin GP; Furth EE; Furukawa T; Klein A; Klimstra DS; Kloppel G; Lauwers GY; Longnecker DS; Luttges J; Maitra A; Offerhaus GJ; Pérez-Gallego L; Redston M; Tuveson DA
Cancer Res; 2006 Jan; 66(1):95-106. PubMed ID: 16397221
[TBL] [Abstract][Full Text] [Related]
4. Validity of mouse mammary tumour models for human breast cancer: comparative pathology.
Cardiff RD
Microsc Res Tech; 2001 Jan; 52(2):224-30. PubMed ID: 11169869
[TBL] [Abstract][Full Text] [Related]
5. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
6. [Application and recent advances of laboratory mouse in human cancer research].
Liu EQ; Kitajima S; Morimoto M
Ai Zheng; 2005 Feb; 24(2):249-54. PubMed ID: 15694046
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of human cancer consortium symposium on nervous system tumors.
Gutmann DH; Baker SJ; Giovannini M; Garbow J; Weiss W
Cancer Res; 2003 Jun; 63(11):3001-4. PubMed ID: 12782610
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.
Namba R; Maglione JE; Young LJ; Borowsky AD; Cardiff RD; MacLeod CL; Gregg JP
Mol Cancer Res; 2004 Aug; 2(8):453-63. PubMed ID: 15328372
[TBL] [Abstract][Full Text] [Related]
9. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
Klein RD
Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered models have advantages over xenografts for preclinical studies.
Becher OJ; Holland EC
Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
[TBL] [Abstract][Full Text] [Related]
11. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
Singh M; Johnson L
Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
[TBL] [Abstract][Full Text] [Related]
12. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
13. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.
Cardiff RD; Anver MR; Gusterson BA; Hennighausen L; Jensen RA; Merino MJ; Rehm S; Russo J; Tavassoli FA; Wakefield LM; Ward JM; Green JE
Oncogene; 2000 Feb; 19(8):968-88. PubMed ID: 10713680
[TBL] [Abstract][Full Text] [Related]
14. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
International Liaison Committee on Resuscitation
Pediatrics; 2006 May; 117(5):e955-77. PubMed ID: 16618790
[TBL] [Abstract][Full Text] [Related]
15. The Mouse Tumor Biology Database: a public resource for cancer genetics and pathology of the mouse.
Näf D; Krupke DM; Sundberg JP; Eppig JT; Bult CJ
Cancer Res; 2002 Mar; 62(5):1235-40. PubMed ID: 11888882
[TBL] [Abstract][Full Text] [Related]
16. The Mouse Tumor Biology Database: integrated access to mouse cancer biology data.
Krupke D; Näf D; Vincent M; Allio T; Mikaelian I; Sundberg J; Bult C; Eppig J
Exp Lung Res; 2005 Mar; 31(2):259-70. PubMed ID: 15824024
[TBL] [Abstract][Full Text] [Related]
17. Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic.
Mossbrugger I; Hoelzlwimmer G; Calzada-Wack J; Quintanilla-Martinez L
Verh Dtsch Ges Pathol; 2007; 91():98-103. PubMed ID: 18314602
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of new transgenic mouse models in glioma research.
Sonabend AM; Ulasov IV; Lesniak MS
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
[TBL] [Abstract][Full Text] [Related]
19. Harnessing preclinical mouse models to inform human clinical cancer trials.
Gutmann DH; Hunter-Schaedle K; Shannon KM
J Clin Invest; 2006 Apr; 116(4):847-52. PubMed ID: 16585951
[TBL] [Abstract][Full Text] [Related]
20. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
